Metabolic syndrome in indigenous communities in Mexico: a descriptive and cross-sectional study

An Amerindian genetic background could play an important role in susceptibility to metabolic diseases, which have alarmingly increased in recent decades. Mexico has one of the highest prevalences of metabolic disease worldwide. The purpose of this study was to determine the prevalence of metabolic s...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 20; no. 1; p. 339
Main Authors Mendoza-Caamal, Elvia Cristina, Barajas-Olmos, Francisco, García-Ortiz, Humberto, Cicerón-Arellano, Isabel, Martínez-Hernández, Angélica, Córdova, Emilio J, Esparza-Aguilar, Marcelino, Contreras-Cubas, Cecilia, Centeno-Cruz, Federico, Cid-Soto, Miguel, Morales-Marín, Mirna Edith, Reséndiz-Rodríguez, Adriana, Jiménez-Ruiz, Juan Luis, Salas-Martínez, María Guadalupe, Saldaña-Alvarez, Yolanda, Mirzaeicheshmeh, Elaheh, Rojas-Martínez, María Rosalba, Orozco, Lorena
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 17.03.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An Amerindian genetic background could play an important role in susceptibility to metabolic diseases, which have alarmingly increased in recent decades. Mexico has one of the highest prevalences of metabolic disease worldwide. The purpose of this study was to determine the prevalence of metabolic syndrome and its components in a population with high Amerindian ancestry. We performed a descriptive, quantitative, and analytical cross-sectional study of 2596 adult indigenous volunteers from 60 different ethnic groups. Metabolic syndrome and its components were evaluated using the American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement criteria. The overall prevalence of metabolic syndrome in the indigenous Mexican population was 50.3%. Although females had a higher prevalence than males (55.6% vs. 38.2%), the males presented with combinations of metabolic syndrome components that confer a higher risk of cardiovascular disease. The most frequent metabolic syndrome component in both genders was low HDL-cholesterol levels (75.8%). Central obesity was the second most frequent component in females (61%), though it had a low prevalence in males (16.5%). The overall prevalence of elevated blood pressure was 42.7% and was higher in males than females (48.8 vs. 40%). We found no gender differences in the overall prevalence of elevated triglycerides (56.7%) or fasting glucose (27.9%). We documented that individuals with Amerindian ancestry have a high prevalence of metabolic syndrome. Health policies are needed to control the development of metabolic disorders in a population with high genetic risk.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1471-2458
1471-2458
DOI:10.1186/s12889-020-8378-5